Over 33 years of pharmaceutical industry experience spanning Global and Regional Marketing, Strategy, Product Development, Market Development, and Sales. He began his career at Merck & Co., Inc., where he demonstrated leadership across more than 10 therapeutic areas and brands.

Kyle helped launch KEYTRUDA® (pembrolizumab), leading multiple global and U.S. marketing functions that helped establish it as the most successful oncology product in history (>$29B in annual sales). He also collaborated closely with research and regulatory teams to shape clinical programs, regulatory filings, and global approvals.

He earned degrees in Biology and Industrial Distribution from Texas A&M University. Kyle's deep expertise in commercialization, healthcare strategy, and market development will help provide valuable expertise into product development, regulatory strategy, and operations for Pramana.